Understanding Bile Duct Cancer
For the 6,000 people in the UK diagnosed with bile duct cancer each year, the prognosis is grim. Up to 70% of patients will die within just 12 months. This rare cancer develops in the bile ducts, connecting the liver and gall bladder, making it difficult to detect until it's often too late.
New Treatment Breakthrough
Doctors in the UK are pioneering a groundbreaking study that matches a patient's tumor with specific medicines to combat bile duct cancer. Some patients have seen remission, while others now qualify for surgery. This innovative approach aims to set new standards for treating this deadly disease.
Paving the Way for Longer Lives
The SAFIR-ABC10 trial, led by University College London Hospitals and University College London, offers hope for those diagnosed with bile duct cancer. By providing personalized treatment options based on genetic profiling, this trial could extend the lives of patients, offering new avenues beyond traditional chemotherapy.
